Generic Triple Therapy Shows Promise in Cystic Fibrosis

Published Date: 01 Jul 2026

A generic formulation of elexacaftor-tezacaftor-ivacaftor shows real-world benefits and appears safe in children and adolescents with cystic fibrosis, a study finds.

Read Full News

Latest News


News All Time

HTTP error: 503 HTTP error: 503HTTP error: 503 HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chromatin organization linked to p53 tumor suppression mechanism

2.

Despite Medicare Coverage, Cancer Genomic Testing Still Low

3.

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

4.

New protein target discovered for childhood medulloblastomas

5.

CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot